Home Add to Favorite Contact Submit  
           22 April, 2021

Category:  Press

 » Health & Fitness


Press releases Records 351-354 of 354  |  Go to << Prior 1 ... 34 35 36 page 
Order by  Date Added  |  Popularity  |  Alphabet
Top Malaysian Cancer Center Begins Treatments Using World's Most Versatile and Advanced Radiotherapy Machine (Popularity: )
A leading cancer center in Malaysia has begun offering patients state-of-the-art radiotherapy treatments using a new Trilogy(R) linear accelerator from Varian Medical Systems. The NCI Cancer Hospital in Nilai, south of Kuala Lumpur, has launched treatment programs offering the latest in high-precision radiotherapy techniques, including intensity modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT) and stereotactic radiosurgery. More than 40 patients have been treated on the versatile, all-in-one Trilogy machine since treatments ...

Fat Fighter FBCx Receives Kosher Certification (Popularity: )
ArtJen Complexus Holdings Corp. is pleased to announce that they have received kosher certification from Rabbi Gabriel Zinner of Brooklyn, NY for FBCx, the fat fighting fiber tablet. The popularity of FBCx is steadily growing so we are very pleased to be able to provide FBCx as Kosher certified According to ArtJen President, Dr. Catherine Jen, kosher certification is further evidence of the high standards to which FBCx is manufactured ...

TheTennisChannel.Com Celebrates Tennis' Premier Grass-Court Event with Content Package to Coincide with Wimbledon (Popularity: )
The Tennis Channel, the only 24-hour, television-based multimedia destination dedicated to tennis and the healthy, active lifestyle that surrounds it, has unveiled an online content package to coincide with Wimbledon, one of the most prestigious events in all of organized sports. In conjunction with London’s annual grass-court tennis tournament, www.TheTennisChannel.com features news, previews, updates, travel information, broadband video, message board access and a variety of other content fully dedicated to ...

Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries (Popularity: )
Corgentech Inc. (Nasdaq: CGTK) today reported positive, top-line clinical data from a Phase 2 clinical trial in total knee replacement surgeries showing that 4975, the company's novel, long-acting, non-opioid drug candidate being developed for site-specific, moderate-to-severe pain, demonstrated pain reduction at all pre-specified time intervals in the study, including statistically significant pain relief at day one (p=0.0273) and at day 14 (p=0.0071). The difference in average daily pain scores between ...